Neurelis Announces Completion of Senior Management Team Buildout to Support the Anticipated Commercial Launch of VALTOCO(TM)

Neurelis' lead product candidate for seizures, VALTOCO™ (diazepam nasal spray), currently under FDA review Company's team members are all seasoned pharmaceutical industry executives with vast experience in CNS and epilepsy SAN DIEGO, April 22, 2019 -... Biopharmaceuticals, Drug Delivery, Neurology, Personnel Neurelis, VALTOCO, diazepam, epilepsy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news